1,581 results on '"Nakanishi, Yoichi"'
Search Results
52. Conformational Change of the Hairpin-like-structured Robo2 Ectodomain Allows NELL1/2 Binding
53. Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockade
54. Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan
55. FRET-based detection of isozyme-specific activities of transglutaminases
56. Longitudinal assessment of pain management with the pain management index in cancer outpatients receiving chemotherapy
57. Population pharmacokinetic–pharmacodynamic modeling and model-based prediction of docetaxel-induced neutropenia in Japanese patients with non-small cell lung cancer
58. Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis
59. Current status and future perspectives of cooperative study groups for lung cancer in Japan
60. Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
61. Letter to the Editor: Speedy Plant Genotyping by SDS-Tolerant Cyclodextrin-PCR
62. Precise Quantification of Molybdate In Vitro by the FRET-Based Nanosensor ‘MolyProbe’
63. Surgery for Small Cell Lung Cancer: A Retrospective Analysis of 243 Patients from Japanese Lung Cancer Registry in 2004
64. Retrospective analysis of nursing and healthcare-associated pneumonia: Analysis of adverse prognostic factors and validity of the selection criteria
65. Genetic polymorphisms involved in the inflammatory response and lung cancer risk: A case-control study in Japan
66. Purification of zebrafish erythrocytes as a means of identifying a novel regulator of haematopoiesis
67. Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non–Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis
68. Expression of cytokine and extracellular matrix mRNAs in fetal hepatic stellate cells
69. Core regulatory components of the PHO pathway are conserved in the methylotrophic yeast Hansenula polymorpha
70. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan
71. Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial
72. Lessons learned from staging the Olympics during a pandemic
73. Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes
74. Additional file 1 of A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
75. Additional file 2 of A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
76. Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
77. Absence of LTB4/BLT1 axis facilitates generation of mouse GM-CSF–induced long-lasting antitumor immunologic memory by enhancing innate and adaptive immune systems
78. A Phase I Study of Chemoradiotherapy With Use of Involved-Field Conformal Radiotherapy and Accelerated Hyperfractionation for Stage III Non-Small Cell Lung Cancer: WJTOG 3305
79. Identifying risk factors for refractory febrile neutropenia in patients with lung cancer
80. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease
81. The clinical efficacy and safety of micafungin–itraconazole combination therapy in patients with pulmonary aspergilloma
82. Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations
83. Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression
84. SPS-9 - Safety Profile of Nivolumab in Japanese NSCLC Pts: Interim Results from Post-marketing All-Case Surveillance in Japan
85. Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia/lymphoma
86. Severe acute interstitial lung disease in a patient with anaplastic lymphoma kinase rearrangement–positive non–small cell lung cancer treated with alectinib
87. Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over Decade
88. A Zinc Chelator TPEN Attenuates Airway Hyperresponsiveness Airway Inflammation in Mice In Vivo
89. Real‐world safety of nivolumab in patients with non‐small‐cell lung cancer in Japan: Postmarketing surveillance
90. EPHX1 Polymorphisms and the Risk of Lung Cancer: A HuGE Review
91. Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non–small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial
92. Hypoalbuminemia, influenza vaccination and other factors related to the development of pneumonia acquired outside hospitals in southern Japan: A case–control study
93. Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401
94. Molecular Pathways Governing Development of Vascular Endothelial Cells from ES/iPS Cells
95. Japanese Lung Cancer Registry Study: First Prospective Enrollment of a Large Number of Surgical and Nonsurgical Cases in 2002
96. Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer
97. Infected complex renal cysts during crizotinib therapy in a patient with non–small cell lung cancer positive for ALK rearrangement
98. Functional expression of Acetabularia acetabulum vacuolar H + -pyrophosphatase in a yeast VMA3-deficient strain
99. An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing’s Syndrome and Autonomous Cortisol Secretion
100. Pulse oximetry is an essential tool that saves lives: a call for standardisation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.